We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
CNS SPECIALIST / DIFFERENTIATED PRODUCTS / OUR PORTFOLIO
CNS portfolio

Comprehensive CNS Portfolio

In the CNS area we offer patients and medical specialists therapeutic solutions that cover from prevention with Consumer Healthcare Products, to standard treatment with Standard Generics to Value Added Medicines.

With our broad portfolio in this area we contribute to improving patients’ health and mental well-being and address their unmet mental health needs.
  • full coverage of psychiatrists & neurologists Comprehensive marketed CNS portfolio tailored to the different European market needs
  • partner for specialist doctors Unique molecules in the market
  • Advisory board with 6 KOLs Added value dosage forms and strengths
  • CNS foundation Cross-country synergies in portfolio
  • CNS
    VALUE ADDED
    MEDICINES
    CNS VALUE ADDED MEDICINES
    View
  • CNS
    STANDARD GENERICS
    CNS STANDARD GENERICS
    View
  • CNS
    CONSUMER HEALTHCARE
    CNS NUTRACEUTICALS
    View
CNS pharmaceuticals
  • Our strength comes from offering one of the most comprehensive product portfolios in CNS pharmaceuticals in Europe
  • We offer a complete spectrum of therapeutic options in Epilepsy, Parkinson's, Psychosis / Schizophrenia, Depression and Alzheimer's as well as a growing portfolio in other CNS indications
  • Our product portfolio includes >130 CNS molecules in the categories of Analgesics, Antidementia agents, Antidepressants, Antiepileptics, Antiparkinson agents, Antipsychotics, Anxiolytics/Hypnotics and other CNS categories
Comprehensive marketed CNS portfolio tailored to the different European market needs
  • We are experts in improving existing pharmaceutical forms and in upgrading new products. In some cases, new patient-friendly products and formulations are developed at the request of, and in close consultation with, medical specialists

  • Our extensive portfolio includes not only high-turnover products and conventional pharmaceutical forms but, thanks to Neuraxpharm’s intense patient focus, we can also provide less popular preparations and offer products in a comprehensive, patient-friendly range of active substances in well-tolerated forms, along with a very wide range of dosages for personalised treatment
Unique molecules in the market


  • It is part of Neuraxpharm’s very identity to be able to offer patients and medical specialists affordable cutting-edge CNS drugs

  • Medicines are improved by innovative advancements in their pharmaceutical forms and by more practical dosing
cutting-edge CNS pharmaceuticals



  • The integration of all the companies within Neuraxpharm allows us to establish both growth and cross-business synergies in many strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion